Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Evan Garfein, chief of plastic and reconstructive surgical procedure at Montefiore, highlighted Breast Most cancers Consciousness Month as an opportunity to...
Sarcoma is a uncommon and sophisticated kind of most cancers that varieties in connective tissues, which embrace bones, muscular tissues, fats, tendons,...
